XERS XERIS BIOPHARMA HOLDINGS INC Management Changes 8-K Filing 2025 - Management Changes Mr. Ken Johnson will retire as Senior VP on April 1, 2025, and Dr. Anh Nguyen has been appointed as Chief Medical Officer effective February 24, 2025.Get access to all SEC 8-K filings of the XERIS BIOPHARMA HOLDINGS INC